|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Study Type: | Interventional |
|---|---|
| Study Design: | Allocation: Randomized; Endpoint Classification: Safety/Efficacy Study; Intervention Model: Parallel Assignment; Masking: Double Blind (Subject, Outcomes Assessor); Primary Purpose: Prevention |
| Condition: |
Dental Caries |
| Interventions: |
Device: Ozone treatment Device: Placebo treatment |
Participant Flow
| Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations |
|---|
| No text entered. |
| Significant events and approaches for the overall study following participant enrollment, but prior to group assignment |
|---|
| No text entered. |
| Description | |
|---|---|
| Ozone Treatment and Placebo Treatment | 60-second Ozone device treatment compared to 60-second Placebo device treatment. Study utilized split-mouth design. The paired treatment assignment for the two teeth within each subject was performed according to a randomization table provided by the Biometrician. Randomization of teeth to Ozone treatment or Placebo treatment was stratifed according to tooth similarity. |
| Ozone Treatment and Placebo Treatment | |
|---|---|
| STARTED | 394 |
| COMPLETED | 295 |
| NOT COMPLETED | 99 |
| Protocol Violation | 99 |
Baseline Characteristics
| Description | |
|---|---|
| Ozone Treatment/Placebo Treatment | Study utilized split-mouth design. Each participant had two teeth selected at the start of the study. Each participant was then randomized to receive Ozone treatment on a randomly selected study tooth for 60 seconds and Placebo treatment on a randomly selected study tooth for 60 seconds. |
| Ozone Treatment/Placebo Treatment | |
|---|---|
|
Number of Participants
[units: participants] |
394 |
|
Age
[units: participants] |
|
| <=18 years | 102 |
| Between 18 and 65 years | 292 |
| >=65 years | 0 |
|
Age
[units: years] Mean ± Standard Deviation |
22.9 ± 7.2 |
|
Gender
[units: participants] |
|
| Female | 202 |
| Male | 192 |
|
Region of Enrollment
[units: participants] |
|
| United States | 394 |
Outcome Measures
| 1. Primary: | ICDAS Severity Value [ Time Frame: Baseline and One Year ] |
| 2. Secondary: | Change in Caries Lesion Activity [ Time Frame: Baseline and one year ] |
| 3. Secondary: | Progression of Radiographic Scores at 12 Months [ Time Frame: one year ] |
| 4. Secondary: | Laser Fluorescence Progression-12 Month (Increase From <=20 to >=30) [ Time Frame: one year ] |
| 5. Secondary: | Laser Fluorescence Progression-12 Month (Increase at Least 10) [ Time Frame: one year ] |
More Information
| Principal Investigators are NOT employed by the organization sponsoring the study. |
| There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. |
| Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data |
|---|
| Study length may have been too brief to permit progression of early stage caries; Low caries increment in study population; Difficult to establish that lesions were truly active at baseline. |
| Responsible Party: | Dr. Domenick Zero, Indiana University School of Dentistry |
| ClinicalTrials.gov Identifier: | NCT00495495 History of Changes |
| Other Study ID Numbers: | 07-D-187, IDE G50008, Clinical Trials. gov |
| Study First Received: | July 1, 2007 |
| Results First Received: | October 12, 2010 |
| Last Updated: | January 5, 2011 |
| Health Authority: | United States: Food and Drug Administration |